JPS60255735A - 経口用及び座薬に特に適したスルホーアデノシル‐Ｌ‐メチオニン（ＳＡＭｅ）塩からなる製剤組成物 - Google Patents
経口用及び座薬に特に適したスルホーアデノシル‐Ｌ‐メチオニン（ＳＡＭｅ）塩からなる製剤組成物Info
- Publication number
- JPS60255735A JPS60255735A JP60102794A JP10279485A JPS60255735A JP S60255735 A JPS60255735 A JP S60255735A JP 60102794 A JP60102794 A JP 60102794A JP 10279485 A JP10279485 A JP 10279485A JP S60255735 A JPS60255735 A JP S60255735A
- Authority
- JP
- Japan
- Prior art keywords
- sulfonate
- salt
- same
- composition
- sams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000829 suppository Substances 0.000 title claims description 7
- FVSFGYXQNHBRHP-TWBCTODHSA-N (2S)-2-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-sulfoamino]-4-methylsulfanylbutanoic acid Chemical class O[C@@H]1[C@H](O)[C@@H](CN([C@@H](CCSC)C(O)=O)S(O)(=O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 FVSFGYXQNHBRHP-TWBCTODHSA-N 0.000 title claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 5
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 24
- 238000009472 formulation Methods 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 16
- 159000000000 sodium salts Chemical class 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 239000013545 self-assembled monolayer Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims description 4
- XHJLCRULHISREH-UHFFFAOYSA-N 4-methylbenzenesulfonic acid;sulfo hydrogen sulfate Chemical group OS(=O)(=O)OS(O)(=O)=O.CC1=CC=C(S(O)(=O)=O)C=C1 XHJLCRULHISREH-UHFFFAOYSA-N 0.000 claims description 3
- 238000000682 scanning probe acoustic microscopy Methods 0.000 claims description 3
- -1 sulfur ester Chemical class 0.000 claims description 3
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 2
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- CACRRXGTWZXOAU-UHFFFAOYSA-N octadecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCCCCCCCS(O)(=O)=O CACRRXGTWZXOAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- MYOWBHNETUSQPA-UHFFFAOYSA-N tetradecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCCCS(O)(=O)=O MYOWBHNETUSQPA-UHFFFAOYSA-N 0.000 claims description 2
- SJEYEFOHSMBQIX-UHFFFAOYSA-N undecane-1-sulfonic acid Chemical compound CCCCCCCCCCCS(O)(=O)=O SJEYEFOHSMBQIX-UHFFFAOYSA-N 0.000 claims description 2
- 229960000878 docusate sodium Drugs 0.000 claims 2
- KVGOXGQSTGQXDD-UHFFFAOYSA-N 1-decane-sulfonic-acid Chemical group CCCCCCCCCCS(O)(=O)=O KVGOXGQSTGQXDD-UHFFFAOYSA-N 0.000 claims 1
- VERAMNDAEAQRGS-UHFFFAOYSA-N butane-1,4-disulfonic acid Chemical compound OS(=O)(=O)CCCCS(O)(=O)=O VERAMNDAEAQRGS-UHFFFAOYSA-N 0.000 claims 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 claims 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229910021653 sulphate ion Inorganic materials 0.000 claims 1
- 235000008247 Echinochloa frumentacea Nutrition 0.000 description 7
- 240000004072 Panicum sumatrense Species 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 5
- LEUIUWYZAHKPSE-UHFFFAOYSA-L disodium;butane-1,4-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)CCCCS([O-])(=O)=O LEUIUWYZAHKPSE-UHFFFAOYSA-L 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 241000700159 Rattus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 2
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 2
- AYFACLKQYVTXNS-UHFFFAOYSA-M sodium;tetradecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCCCS([O-])(=O)=O AYFACLKQYVTXNS-UHFFFAOYSA-M 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101100345160 Caenorhabditis elegans sams-1 gene Proteins 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- SSILHZFTFWOUJR-UHFFFAOYSA-M hexadecane-1-sulfonate Chemical compound CCCCCCCCCCCCCCCCS([O-])(=O)=O SSILHZFTFWOUJR-UHFFFAOYSA-M 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- PNGBYKXZVCIZRN-UHFFFAOYSA-M sodium;hexadecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCS([O-])(=O)=O PNGBYKXZVCIZRN-UHFFFAOYSA-M 0.000 description 1
- KBAFDSIZQYCDPK-UHFFFAOYSA-M sodium;octadecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCS([O-])(=O)=O KBAFDSIZQYCDPK-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20939/84A IT1173991B (it) | 1984-05-16 | 1984-05-16 | Composizioni farmaceutiche comprendenti solfo-afenosil-l-metionina (same) particolarmente adatte per uso orale e per supposte |
| IT20939A/84 | 1984-05-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60255735A true JPS60255735A (ja) | 1985-12-17 |
| JPH0517204B2 JPH0517204B2 (enrdf_load_stackoverflow) | 1993-03-08 |
Family
ID=11174353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60102794A Granted JPS60255735A (ja) | 1984-05-16 | 1985-05-16 | 経口用及び座薬に特に適したスルホーアデノシル‐Ｌ‐メチオニン（ＳＡＭｅ）塩からなる製剤組成物 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS60255735A (enrdf_load_stackoverflow) |
| IT (1) | IT1173991B (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471088B2 (en) | 2006-03-31 | 2019-11-12 | Gnosis Spa | Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5264418A (en) * | 1975-11-20 | 1977-05-27 | Toyama Chem Co Ltd | Method for increasing absorption of novel penicillin in rectal adminis tration |
| JPS5341418A (en) * | 1976-09-24 | 1978-04-14 | Kyowa Hakko Kogyo Co Ltd | Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration |
| JPS5391113A (en) * | 1977-01-21 | 1978-08-10 | Meiji Seika Kaisha Ltd | Preparation of suppository of antibiotics |
| JPS5699499A (en) * | 1980-01-10 | 1981-08-10 | Kanegafuchi Chem Ind Co Ltd | Composition containing s-adenosyl-l-methionine, and its preparation |
-
1984
- 1984-05-16 IT IT20939/84A patent/IT1173991B/it active
-
1985
- 1985-05-16 JP JP60102794A patent/JPS60255735A/ja active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5264418A (en) * | 1975-11-20 | 1977-05-27 | Toyama Chem Co Ltd | Method for increasing absorption of novel penicillin in rectal adminis tration |
| JPS5341418A (en) * | 1976-09-24 | 1978-04-14 | Kyowa Hakko Kogyo Co Ltd | Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration |
| JPS5391113A (en) * | 1977-01-21 | 1978-08-10 | Meiji Seika Kaisha Ltd | Preparation of suppository of antibiotics |
| JPS5699499A (en) * | 1980-01-10 | 1981-08-10 | Kanegafuchi Chem Ind Co Ltd | Composition containing s-adenosyl-l-methionine, and its preparation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471088B2 (en) | 2006-03-31 | 2019-11-12 | Gnosis Spa | Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them |
| EP2007479B1 (en) * | 2006-03-31 | 2019-12-04 | Gnosis S.p.A. | Solid oral compositions based on S-adenosyl methionine salt and process for obtaining them |
Also Published As
| Publication number | Publication date |
|---|---|
| IT8420939A1 (it) | 1985-11-16 |
| IT1173991B (it) | 1987-06-24 |
| JPH0517204B2 (enrdf_load_stackoverflow) | 1993-03-08 |
| IT8420939A0 (it) | 1984-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT80453B (pt) | Processo de preparacao de sais estaveis da sulfo-adenosil-l-metionina (same) especialmente adequados para medicamento oral | |
| US3510561A (en) | Sulfone-enhanced heparin absorption through mucous membranes | |
| PT736004E (pt) | (2,4-dissulfofenil)-n-terc-butil-nitrona seus sais e sua utilizacao como agentes farmaceuticos capturadores de radicais livres | |
| CA2083683C (en) | Stable formulation of analapril salt, a process for the preparation thereof and the use thereof | |
| PT88448B (pt) | Processo para a preparacao de composicoes farmaceuticas antiprotozoarias contendo azitromicina ou um seu derivado | |
| CA1121825A (en) | 2-(2-thenoylthio)-propionylglycine: method for its preparation and pharmaceutical formulations containing said compound | |
| BR122021004504B1 (pt) | Uso de um composto antimicrobiano | |
| BRPI0620530A2 (pt) | sais e misturas de 9-oxioacridona-10-ácido acético e 1-alquilamina-1-deoxipolióis, composições farmacêuticas e métodos para tratamento | |
| US4058623A (en) | Prostaglandin-containing lyophilized powders | |
| JPH07507288A (ja) | デスフェリオキサミン−ｂ塩及び経口的に有効な鉄キレート剤としてのそれらの使用 | |
| JPS6011888B2 (ja) | リウマチ疾患治療薬 | |
| EP0194336A2 (en) | Oral mobenzoxamine preparation | |
| JPS60255735A (ja) | 経口用及び座薬に特に適したスルホーアデノシル‐Ｌ‐メチオニン（ＳＡＭｅ）塩からなる製剤組成物 | |
| US3934036A (en) | N-benzenesulfonyl-β-alanine hydrazide useful as an immunosuppressive agent | |
| JPS6225657B2 (enrdf_load_stackoverflow) | ||
| PT98215B (pt) | Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem | |
| US2799617A (en) | Piperazine adipate compositions and treatment of helminth infections therewith | |
| RU2706692C1 (ru) | Новые сульфопроизводные 2-этил-6-метил-гидроксипиридина | |
| DE69312849T2 (de) | Mercapto-acetamid-derivate | |
| US4419358A (en) | Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it | |
| JP3247695B2 (ja) | エタノール摂取を妨げるチオカルバメートスルホキシド組成物 | |
| PT89742B (pt) | Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas | |
| WO2024123749A1 (en) | Antiviral compounds and methods of making and use thereof | |
| US2196495A (en) | Isopropanolamine salts of theophylline and process of making them | |
| Gulland et al. | The alleged antineuritic properties of certain quinoline and glyoxaline derivatives |